Cite
HARVARD Citation
Schilsky, M. et al. (2022). Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial. Lancet gastroenterology and hepatology. pp. 1092-1102. [Online].